Implementation of programs for the prevention, care and treatment of HIV/AIDS in the Republic of Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 151603CONT17

Opportunity Information: Apply for CDC RFA GH15 151603CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically through CDCs Center for Global Health. It supports ongoing implementation of HIV/AIDS prevention, care, and treatment programs in the Republic of Cote d'Ivoire under the Presidents Emergency Plan for AIDS Relief (PEPFAR). In practical terms, the grant is meant to sustain and strengthen country-level HIV programming that aligns with PEPFAR priorities, typically emphasizing evidence-based interventions, service delivery scale-up, and improvements in the quality and reach of HIV services.

The opportunity is identified by Funding Opportunity Number CDC RFA GH15 151603CONT17, and it falls under the health funding activity category with CFDA number 93.067, which is associated with global HIV/AIDS efforts. Because it is labeled as a continuation opportunity, it is generally intended for organizations that are already implementing CDC/PEPFAR-supported work in Cote d'Ivoire and are seeking additional support to continue or expand previously funded activities, rather than brand-new applicants proposing unrelated projects. The eligible applicant category is listed as "Others" with direction to consult the additional eligibility language in the full notice, which usually means eligibility may be limited or conditioned (for example, tied to current recipients, specific partners, or organizations meeting defined programmatic requirements).

The funding instrument is a cooperative agreement, which matters because it signals substantial involvement by the CDC in the project. Unlike a standard grant where the recipient has more independent control, a cooperative agreement typically involves ongoing technical collaboration, joint planning, monitoring, and coordination with CDC staff. In the PEPFAR context, this often includes alignment with national strategies, adherence to PEPFAR technical guidance, participation in coordination forums, and performance monitoring against agreed targets and indicators.

The programmatic scope is broad but focused on the HIV continuum: prevention, care, and treatment. While the brief synopsis does not list specific activities, initiatives under this type of PEPFAR/CDC award commonly include a mix of HIV testing services and linkage to care; antiretroviral therapy (ART) initiation and retention support; viral load monitoring and improvement of viral suppression; prevention interventions for priority populations; prevention of mother-to-child transmission (PMTCT) and pediatric HIV care; laboratory systems strengthening; data systems and surveillance support; quality improvement in facilities and community programs; and workforce development such as training and mentorship for clinicians, laboratorians, data staff, and community health workers. Many awards also emphasize integration with tuberculosis services, sexual and reproductive health services, and broader health system functions where doing so improves HIV outcomes.

Key administrative details include an opportunity creation date of October 10, 2016, with an original closing date of December 13, 2016. The notice lists an expected number of awards of 10, suggesting CDC anticipated multiple implementing partners or multiple continuation awards under the same umbrella announcement. The award ceiling is shown as 0, which typically indicates that a specific maximum funding level was not provided in the summarized data extract, or that the ceiling was to be defined elsewhere in the full funding announcement or through continuation award negotiations tied to availability of funds, approved work plans, and PEPFAR country operational planning decisions.

Overall, this opportunity is best understood as CDCs mechanism to continue supporting PEPFAR-backed HIV/AIDS programming in Cote d'Ivoire through collaborative, performance-driven implementation. Recipients would be expected to carry forward established work, meet PEPFAR reporting and accountability requirements, coordinate closely with CDC and national stakeholders, and demonstrate measurable progress along prevention and treatment goals consistent with the countrys epidemic control strategy.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Implementation of programs for the prevention, care and treatment of HIV/AIDS in the Republic of Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 10, 2016.
• Applicants must submit their applications by Dec 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 151603CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: